Literature DB >> 33951586

Pseudomonas aeruginosa Pneumonia Causes a Loss of Type-3 and an Increase in Type-1 Innate Lymphoid Cells in the Gut.

Anja Fuchs1, Sarbani Ghosh1, Shin-Wen Chang1, Grant V Bochicchio1, Isaiah R Turnbull2.   

Abstract

BACKGROUND: Sepsis induces gut barrier dysfunction characterized by increased gut epithelial apoptosis and increased intestinal permeability. The cytokine IL-22 has been demonstrated to regulate gut barrier function. Type-3 innate lymphoid cells (ILC3) are the predominate source of IL-22 in the GI tract. We hypothesized that sepsis may cause changes to the gut ILC3/IL-22 axis.
MATERIALS AND METHODS: Sepsis was induced in WT and IL-22 KO mice by Pseudomonas aeruginosa pneumonia. Changes in gut-associated leukocyte populations were determined by flow-cytometry and ILC-associated transcripts were measured by RT-PCR. The effect of sepsis on gut permeability, pulmonary microbial burden, gut epithelial apoptosis, and survival was compared between WT and IL-22-/- mice.
RESULTS: Sepsis resulted in a significant decrease in the number of ILC3 in the gut, with a reciprocal increase in type-1 ILC (ILC1). Consistent with prior reports, sepsis was associated with increased gut permeability; however there was no difference in gut permeability, gut epithelial apoptosis, pulmonary microbial burden, or survival between WT and IL-22-/- mice.
CONCLUSIONS: Septic pneumonia causes a decrease in gut-associated ILC3 and an associated reciprocal increase in ILC1. This may reflect inflammation-induced conversion of ILC3 to ILC1. Constitutive systemic IL-22 deficiency does not alter sepsis-induced gut barrier dysfunction.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Inflammation; Mucosal immunity; Sepsis

Mesh:

Year:  2021        PMID: 33951586      PMCID: PMC8238906          DOI: 10.1016/j.jss.2021.03.043

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.417


  34 in total

Review 1.  Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut.

Authors:  David Artis
Journal:  Nat Rev Immunol       Date:  2008-06       Impact factor: 53.106

2.  Septic mucosal intraepithelial lymphoid immune suppression: role for nitric oxide not interleukin-10 or transforming growth factor-beta.

Authors:  C S Chung; G Y Song; W Wang; I H Chaudry; A Ayala
Journal:  J Trauma       Date:  2000-05

3.  Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages.

Authors:  Christoph S N Klose; Melanie Flach; Luisa Möhle; Leif Rogell; Thomas Hoyler; Karolina Ebert; Carola Fabiunke; Dietmar Pfeifer; Veronika Sexl; Diogo Fonseca-Pereira; Rita G Domingues; Henrique Veiga-Fernandes; Sebastian J Arnold; Meinrad Busslinger; Ildiko R Dunay; Yakup Tanriver; Andreas Diefenbach
Journal:  Cell       Date:  2014-04-10       Impact factor: 41.582

4.  Conventional NK cells can produce IL-22 and promote host defense in Klebsiella pneumoniae pneumonia.

Authors:  Xin Xu; Ido D Weiss; Hongwei H Zhang; Satya P Singh; Thomas A Wynn; Mark S Wilson; Joshua M Farber
Journal:  J Immunol       Date:  2014-01-17       Impact factor: 5.422

5.  Impact of sex and age on bone marrow immune responses in a murine model of trauma-hemorrhage.

Authors:  Christian P Schneider; Martin G Schwacha; Irshad H Chaudry
Journal:  J Appl Physiol (1985)       Date:  2006-10-05

6.  The epidemiology of sepsis in the United States from 1979 through 2000.

Authors:  Greg S Martin; David M Mannino; Stephanie Eaton; Marc Moss
Journal:  N Engl J Med       Date:  2003-04-17       Impact factor: 91.245

7.  Redundant and pathogenic roles for IL-22 in mycobacterial, protozoan, and helminth infections.

Authors:  Mark S Wilson; Carl G Feng; Daniel L Barber; Felix Yarovinsky; Allen W Cheever; Alan Sher; Michael Grigg; Mary Collins; Lynette Fouser; Thomas A Wynn
Journal:  J Immunol       Date:  2010-03-10       Impact factor: 5.422

8.  Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically ill ICU patients.

Authors:  C J Doig; L R Sutherland; J D Sandham; G H Fick; M Verhoef; J B Meddings
Journal:  Am J Respir Crit Care Med       Date:  1998-08       Impact factor: 21.405

9.  Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues.

Authors:  Jochem H Bernink; Charlotte P Peters; Marius Munneke; Anje A te Velde; Sybren L Meijer; Kees Weijer; Hulda S Hreggvidsdottir; Sigrid E Heinsbroek; Nicolas Legrand; Christianne J Buskens; Willem A Bemelman; Jenny M Mjösberg; Hergen Spits
Journal:  Nat Immunol       Date:  2013-01-20       Impact factor: 25.606

10.  A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity.

Authors:  Marina Cella; Anja Fuchs; William Vermi; Fabio Facchetti; Karel Otero; Jochen K M Lennerz; Jason M Doherty; Jason C Mills; Marco Colonna
Journal:  Nature       Date:  2008-11-02       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.